𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement of lung function in patients with systemic sclerosis after 6

✍ Scribed by Predrag Ostojic; Nemanja Damjanov

Publisher
Springer
Year
2006
Tongue
English
Weight
73 KB
Volume
25
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Improvement of vascular endothelial func
Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis
✍ P. P. Sfikakis; C. Papamichael; K. S. Stamatelopoulos; D. Tousoulis; K. G. Fragi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

## Abstract ## Objective Increased endothelin activity may play a role in the pathogenesis of vascular injury, a primary feature of systemic sclerosis (SSc; scleroderma). Our goal was to test the hypothesis that treatment with the oral endothelin receptor antagonist bosentan might improve vascular

D-penicillamine treatment of lung involv
D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma)
✍ Thomas A. Medsger Jr. πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 2 views

D-penicillamine has been used to treat systemic sclerosis (scleroderma) for nearly two decades. Improvement in cutaneous fibrosis in patients treated with this drug has been documented in a number of uncontrolled studies (1). The effect of D-penicillamine on established visceral involvement due to s